[PDF][PDF] Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow …
J Schetelig, A van Biezen, R Brand… - Journal of Clinical …, 2008 - researchgate.net
J Schetelig, A van Biezen, R Brand, D Caballero, R Martino, M Itala, JA García-Marco…
Journal of Clinical Oncology, 2008•researchgate.netPurpose Patients with chronic lymphocytic leukemia (CLL) and 17p deletion (17p–) have a
poor prognosis. Although allogeneic hematopoietic stem-cell transplantation (HCT) has the
potential to cure patients with advanced CLL, it is not known whether this holds true for
patients with 17p–CLL.
poor prognosis. Although allogeneic hematopoietic stem-cell transplantation (HCT) has the
potential to cure patients with advanced CLL, it is not known whether this holds true for
patients with 17p–CLL.
Purpose
Patients with chronic lymphocytic leukemia (CLL) and 17p deletion (17p–) have a poor prognosis. Although allogeneic hematopoietic stem-cell transplantation (HCT) has the potential to cure patients with advanced CLL, it is not known whether this holds true for patients with 17p–CLL.
researchgate.net